Structure Therapeutics Inc. (GPCR) Financials

GPCR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.5 billion 61.0 million
Dec. 31, 2025 1.6 billion 67.5 million
Sept. 30, 2025 832.2 million 62.1 million
June 30, 2025 816.4 million 44.4 million

GPCR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 14.1 million 11.6 million
Dec. 31, 2025 -65.9 million 8.1 million
Sept. 30, 2025 -52.6 million 7.5 million
June 30, 2025 -54.8 million 7.5 million

GPCR Net Income

No data available :(

GPCR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.5 billion 3.2 million -
Dec. 31, 2025 1.4 billion 3.6 million 6.5 million
Sept. 30, 2025 799.0 million 4.3 million 7.1 million
June 30, 2025 786.5 million - 7.7 million

GPCR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 72.4 million
Dec. 31, 2025 59.2 million
Sept. 30, 2025 58.5 million
June 30, 2025 57.9 million

GPCR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.2 million 66.7 million 22.9 million -
Dec. 31, 2025 1.5 million 68.7 million 17.6 million -
Sept. 30, 2025 1.6 million 59.0 million 14.8 million -
June 30, 2025 232000 54.7 million 15.7 million -

GPCR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 1.2 million
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - 853991

GPCR

Price: $49.12

52 week price:
15.80
94.90

Earnings Per Share: -2.66 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 3.1 billion

Links: